Aspire Pharma/Caragen
Transaction details
The proposed acquisition by Aspire Pharma Limited, which is ultimately controlled by funds managed by H.I.G. Capital LLC of sole control of Caragen Limited, has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:11 November 2025
- Publication date:11 November 2025
- Economic sector:Wholesale & retail trade - G
- Economic sub-sector:Wholesale trade - G.46
- Simplified merger:Yes
- Outcome:Cleared
Documents
M.25.075 Merger AnnouncementPDF | 108 KBM.25.075 Merger Announcement PDF | 108 KB - Opens in new window
M.25.075 DeterminationPDF | 214 KBM.25.075 Determination PDF | 214 KB - Opens in new window
Timetable
Parties Involved
Aspire Pharma Limited
Aspire Pharma Limited develops, licenses and sells a range of pharmaceutical products. Aspire Pharma Limited is incorporated in England and Wales. Aspire Pharma Limited is ultimately controlled by H.I.G. Capital LLC.
H.I.G. Capital LLC
HIG Capital LLC is a global private equity and alternative assets investment firm specialising in providing both debt and equity capital to small and mid-sized companies. HIG Capital is incorporated in the State of Delaware, USA.
Caragen Limited
Caragen Limited sources, sells, markets and distributes pharmaceutical products and medical devices. Caragen Limited is incorporated in Ireland.
Contacts
Iseult O'Kelly
